Mamoklam coated tablets 100 mg, No. 40

Mamoklam tab.

p / o captivity.

100mg No. 40

Name ENG

MAMOCLAM

Clinical and pharmacological group

The drug used in diseases of the mammary glands

ATX code

Other drugs for use in gynecology

Dosage

100mg

Structure

Active ingredients: substance Klam" (in terms of dry matter) not less than 0.1 g

lipids not less than 0.04 g

iodine (in organically bound form) not less than 0.1 mg

.Auxiliary substances: MCC

milk sugar

refined sugar

potato starch

Low molecular weight medical PVP

magnesium carbonate

calcium stearic acid

methylcellulose

titanium dioxide pigment grade A

twin 80

copper chlorophyll derivatives

Indications

Treatment of mastopathy both in the form of monotherapy and as part of complex therapy.

INN / Active ingredient

Kelp thallus

Contraindications

Hypersensitivity to drug components

severe kidney disease

hyperthyroidism

toxic adenoma of the thyroid gland, multinodular goiter

furunculosis, chronic pyoderma

hemorrhagic diathesis.

Storage conditions and periods

In a dry place, at a temperature not exceeding 25 degrees.

Expiration date: 2 years

Specifications

Category

Mastopathy

Scope of the drug

Gynecology

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

40

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

MEGA-PHARM CJSC

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Mastopathy is a herbal remedy

Dosage form

Film-coated tablets

Expiration date in days

730

Dosage (volume) of the substance in the preparation

substance "Klam" 100 mg

Package weight, g

45

Mode of application

:

Inside, before meals, a single dose - 1-2 tablets 2-3 times a day at regular intervals during the day (daily dose - 3-6 tablets), the duration of the course of treatment - no more than 1 month.

< br> If necessary, it is recommended to repeat courses of treatment after a break from 2 weeks to 3 months.

Anatomical and therapeutic characteristics

:

G02C Other preparations for the treatment of gynecological diseases

"